Dexamethasone can now be used as an alternative to methylprednisolone, in the case of moderate and severe COVID-19 patients in need of oxygen support and who experience excessive inflammatory response.
Hospitals and other health-care customers advised by Vizient increased orders of the drug by more than 600 percent after the researchers announced their findings last week. Manufacturers were only able to fill around half of those orders, Vizient said.
In this edition of the Explained series, we look at researchers say about the drug.
Celgene intends to launch Pomalidomide Celgene in the EU under the trade name 'IMNOVID", following submission of a regulatory notification to the European Medicines Agency to change the trade name.